Jasper Therapeutics Announces Data from First Transplant-naive Patient in Phase 1 Clinical Trial …,

The trial is evaluating JSP191 as a conditioning agent to enable stem cell transplantation in patients with SCID who are either transplant-naive or who …, The trial is evaluating JSP191 as a conditioning agent to enable stem cell transplantation in patients with SCID who are either transplant-naive or who …, Read More

Scroll to Top